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MethodsAbstract Results 
Penicillium marneffei infection is a rare fungal disease that cause significant 
disease in immunosuppressed patients. The geographical distribution of this 
dimorphic fungus is restricted to Asia, Southeast and Far East, where the disease 
is considered as an indicator of acquired immunodeficiency syndrome (AIDS). 
Case report. A 42-year old Congolese woman living in Lubumbashi was admitted 
at the university hospital of Liège for exploration of a general status impairment. 
She experienced for three months spiking fever, weight loss, productive cough 
with bloody expectorations and progressive dyspnoea.  She reported also to have 
non-bloody mild diarrhoea with abdominal pain.
The HIV antibody status was positive with a low CD4 T lymphocytes count (28/µl). 
Pulmonary infiltrates were visualized on chest radiography and the computed 
tomography revealed the presence of a severe pneumopathy characterised by 
bilateral micronodular lesions. Mediastinal polyadenopathies associated with 
hepato- and splenomegaly were also highlighted. 
Bronchoscopy was performed and bronchial aspirations revealed the presence of 
numerous leucocytes with the presence of intracellular Gram positive organisms 
suggestive of yeasts. Ziehl, Giemsa and Gomori-Grocott staining were also 
performed. Ziehl staining was negative. The morphological aspect given by 
Giemsa staining excluded infection and the PCR specific for T. gondii B1 gene 
was negative. However, Gomori-Grocott staining revealed the presence of 
intracellular oval, elongated, sausage-shaped cells with a single transverse 
septum (3 to 5 µm). Penicillium marneffei was isolated from blood culture and 
respiratory samples. 
Intraveinous amphotericin B treatment was administrated during 15 days followed 
by itraconazole oral administration (200 mg/j). The antimycotic treatment improved 
the patient condition and despite other clinical troubles she was prematurely 
discharged because of financial problems.
Conclusion. Opportunistic agents involved in HIV-infected patients differ in Africa 
and Asia and it is important to be able to make a rapid diagnosis with the aid of an 
experienced laboratory.
Penicillium marneffei is a dimorphic fungus which was 
first isolated from the liver of Chinese bamboo rats by 
Capponi et coll. in 1956 (1). The fungus was identified 
by Segretain in 1959 at the Pasteur institute as a 
pathogenic agent invading the reticular-endothelial 
system of these rats.
P. marneffei is a rare fungal pathogen in humans that is 
responsible for disseminated infection in immuno- 
suppressed patients living in endemic area. The 
geographical distribution of this fungus is restricted to 
Asia, Southeast and Far East, where the disease is 
considered as an indicator of acquired 
immunodeficiency syndrome (AIDS). 
The first case of human infection was reported in 1973 
in an American minister suffering from  Hodgkin disease 
and reporting a past travel in Asia one year before. 
From the years1988-89 there is an increasing number 
of P. marneffei infections among the HIV population  
who come from or who have visited endemic areas of 
South-east Asia.
The mode of contamination is until now not fully clear.
•To point out the importance to know  
the travel history of a patient
•To suggest a systematic detection of 




Endemic areas: south-eastern Asia: 
Indonesia, Laos, Hong-Kong, 
Singapore, Thailand, Myanmar, 
Malaysia, Vietnam, Taiwan and the 






Figure 5. Microscopical 
examination of  P. 
marneffei in BAL culture. 




Admission. A 42-year old congolese female was 
admitted at the University Hospital of Liège on 25th July 
2006 because of a general status impairment despite 
several courses of antibiotics. She was first admitted at 
the University Hospital of Lubumbashi  (RDC) where 
she is living and she was suspected to have 
tuberculosis.
Clinical signs. She experienced for 3 months asthenia, 
anorexia, spiking fever, productive cough with bloody 
expectorations, progressive dyspnea, dysphagia, 
abdominal pain and tenderness. She reported also 
weight loss.
Physical examination revealed hypoventilation of 
lungs bases and hepatosplenomegaly.
Biology. RBC and WBC counts were respectively: 
4.22 106 and 8.15 103 /mm³ (with 85% granulocytes) . 
The CD4+ T lymphocytes number was 18 /mm³.
Infectious serology. HIV, HBV and HCV serology 
were positives.
Imaging examination. CT scan of chest and abdomen 
showed enlarged mediastinal and mesenteric lymph 
nodes. 
Treatment at admission. Antiretroviral therapy 
(Triomune 40 2/d), fluconazole 400 mg 1/d, Bactrim 
100mg 3/d, Acyclovir 400 mg 3/J, Dexamethazone 
12mg 3/D. Antituberculous treatment including 
rifampicin, ethambutol, isoniazid and pyrazinamide was 
also prescribed during the first hospitalisation in 
Lubumbashi.
Laboratory findings
•Bronchoalveolar lavage fluid (BAL) 
Microscopic examination of the BAL fluid 
performed after Giemsa staining and Gram staining 
reported the presence of numerous intracellular 
microorganisms. Gomori methenamine staining was 
also performed to identify the agent (Figures 2-4)
Bacteriological and fungal cultures. Fungal 
cultures performed on Sabouraud agar medium 
showed after 48hs at 28°C the development of a 
filamentous fungus and the apparition of a red 
pigment within the medium after 4 days. The fungus 
was identified as Penicillium marneffei (Figure 5)
Mycobacterial cultures. Microscopic examination of 
3 respiratory samples and cultures were negative. 
•Blood cultures
Blood cultures performed on Bact/Alert (BioMerieux, 
France) and incubated at 35°C were positive after 
48h. The microscopic examination of a Gram stained 
smear revealed the presence of septate filaments. 
The subculture performed on Sabouraud agar 
medium showed the development of P. marneffei
Figure 1. Intracellular yeast-like cells in 
bronchoalveolar lavage fluid (Giemsa stain, x1000) 
Figure 2. Intracellular yeasts in BAL  fluid 
(Gomori methenamin stain, x1000) 
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Figures 3. Extra-cellular short 
filaments in broncho-alveolar 
lavage fluid (Gomori 
methenamine stain, x 2000) 
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Figures 4. Extra-cellular short 
filaments in broncho-alveolar 
lavage fluid (Gomori 
methenamine stain, x 2000) 
•Travel history. The patient who was questioned 
again after the first laboratory findings reported one 
month travel in South China.
•Treatment. Amphotericin B was  administrated 
(0.6 mg/kg/d) for 2 weeks followed by oral 
Itraconazole (200 mg/d).  Dramatic improvement 
(clinical and biological) was observed after 2 weeks 
of Amphotericin B. Abdominal and thoracic scan 
indicated regression of enlarged lymph nodes. She 
was discharged from the hospital under maintenance 
therapy of 200 mg/d Itraconazole.
• Penicillium marneffei infection was suggested on the first microscopic examination of the BAL 
fluid. Giemsa staining did not permit the differentiation of intracellular microorganisms like 
Histoplasma, Leishmania and Toxoplasma. The use of Gomori methenamine silver stain was 
necessary to assess the fungal nature of the microorganisms and to show the specific yeast-like 
cells with transverse septa.
• The patient had no cutaneous involvement and the clinical presentation was similar to 
tuberculosis. It is quite interesting to emphasize that blood infection was also detected by an 
automated blood culture system.
• Since there is a case of PM infection in an African patient living in Germany with no history of 
travel in endemic area (2), it could be hypothesized than the contamination could occur in other 
areas than Southeast Asia. 
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